BioSpace News Archive

Ajinomoto Bio-Pharma Services is pleased to announce the development of a new enzyme for double strand oligonucleotide formation with high productivity.

Ansa Biotechnologies today announced the appointment of Matthew F. McManus, M.D, Ph.D., as Independent Director and Chairperson of the company’s Board of Directors.

Biofrontera Inc. today announced that it will report financial results for the three and 12 months ended December 31, 2022 on Wednesday, March 8, 2023.

IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its fourth quarter and full year 2022 financial and operating results on Wednesday, March 1, 2023.

Cardio Diagnostics Holdings Inc to Debut PrecisionCHD ™ at the American College of Cardiology’s 72nd Annual Scientific Session.

Model N, Inc., the leader in revenue optimization and compliance, announced that Jason Blessing, Chief Executive Officer, and John Ederer, Chief Financial Officer, will present at the JMP Securities Technology Conference on Monday, March 6, 2023 at 8:30 a.m. PT.

Quoin Pharmaceuticals Ltd. today announced the pricing of its “reasonable best efforts” public offering of 24,750,000,000 ordinary shares.

AllCells®, a Discovery Life Sciences™ company and leading provider of critical starting material and services for cell and gene therapy, has announced the expansion of its apheresis network with the addition of two new centers in Houston, Texas, and Huntsville, Alabama.

Heron Therapeutics, Inc. announced that it has entered into a cooperation agreement with two of its shareholders, Rubric Capital Management LP and Velan Capital Investment Management LP.

Lucence announced today that Palmetto GBA, a Medicare administrative contractor and leader in evaluating molecular diagnostic technology through its laboratory technology assessment group for the Molecular Diagnostics Services program (MolDX), has finalized a foundational Local Coverage Determination (LCD) for the LiquidHALLMARK assay.